Synergy Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

SGYP 4.35 +0.06 (1.40%)
price chart
Canaccord Initiates Buy on Synergy Pharmaceuticals Inc; Sees 137% Upside for ...
In a research report issued today, Canaccord analyst Corey Davis initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a Buy rating and a $11 price target, which represents a potential upside of 137% above Thursday's closing ...
Synergy Pharmaceuticals Receives New Coverage from Analysts at Canaccord ...  WKRB News
Synergy Pharmaceuticals Inc (SGYP): Another Breakout Is Close
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has been trading relatively flat in the market recently; that is, until yesterday's massive gains.
Worth Watching Healthcare Sector Stocks- Synergy Pharmaceuticals Inc (SGYP ...  Investor Wired
Synergy Pharmaceuticals (SGYP) Jumps: Stock Rises 7.3%
In the last 30 days, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher over the same time frame, suggesting that more solid trading could be ahead for Synergy Pharmaceuticals. So make sure to ...
Synergy Pharmaceuticals Inc (SGYP) Soars On Billionaire Position
Synergy Pharmaceuticals investors are grinning from ear to ear today as the company's stock continues its incredible day in the market.
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) reported a loss in its first quarter.  Inside Trade
Why Synergy Pharmaceuticals, Inc. Is Surging Higher Today.
What: Shares in Synergy Pharmaceuticals (NASDAQ: SGYP ) jumped by as much as 10% today on reports that the company may be exploring a sale.
Synergy Pharma exploring sale: Bloomberg  Reuters
Cantor Reiterates Buy on Synergy Pharmaceuticals Inc Following 4Q:14 Update
Cantor analyst Irina Rivkind came out with a research note on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the company released its fourth-quarter results, posting a net loss of $30.6M and loss per share of ($0.32), coming in below the FactSet ...
Synergy Pharmaceuticals: Don't Be An April Fool (SGYP)
Synergy Pharmaceuticals is up 59.31% since the publication of my article. Have you taken profits off the table? I have. And I'll tell you why.
Cantor Reiterates Buy on Synergy Pharmaceuticals Inc Following 1Q:15 Update
In a research report issued today, Cantor analyst Irina Rivkind Koffler maintained a Buy rating on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with an $8.50 price target, after the company reported its first-quarter results and outlined its ambitious ...
Synergy Pharmaceuticals Upgraded to Hold at Zacks (SGYP)  Dakota Financial News
Synergy Pharmaceuticals Given a $8.50 Price Target by Cantor Fitzgerald ...  The Legacy
Stock Insights on Synergy Pharmaceuticals Inc. (NASDAQ:SGYP)
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) was among the biggest gainers on the Russell 2000 as the stock popped 9.93% to $3.32, representing a gain of $0.3 per share.
Synergy Pharmaceuticals Inc (SGYP) is Trading Higher on Unusual Volume for ...
Synergy Pharmaceuticals Inc (SGYP) experienced unusually high volume on May. 18, as the stock gained 10.8% to a closing price of $3.90.